Enliven Therapeutics, Inc.

SEC 4 · Filed

0001701247-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 17, 2026

Exercise or conversion by Collins Helen Louise

Security
Stock Option (right to buy)
Code
M
Shares
45,000
Price per share
0.00
Structured facts
{
  "code": "M",
  "date": "2026-02-17",
  "direction": "D",
  "exercise_price": "2.48",
  "expiration": "2031-06-17",
  "footnotes": {
    "F1": "The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2025.",
    "F3": "All of the shares subject to this option are fully vested and exercisable as of the date hereof."
  },
  "owners": [
    {
      "cik": "0001701247",
      "name": "Collins Helen Louise",
      "roles": [
        "officer"
      ],
      "title": "CHIEF MEDICAL OFFICER"
    }
  ],
  "ownership": "D",
  "post_shares": "221268",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Stock Option (right to buy)",
  "shares": "45000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "45000"
}
Insider transactionsEvent date Feb 17, 2026

Sale by Collins Helen Louise

Security
Common Stock
Code
S
Shares
45,000
Price per share
26.17Reported 26.1747
Structured facts
{
  "code": "S",
  "date": "2026-02-17",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2025.",
    "F2": "This transaction was executed in multiple trades at prices ranging from $25.76 to $26.695. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."
  },
  "owners": [
    {
      "cik": "0001701247",
      "name": "Collins Helen Louise",
      "roles": [
        "officer"
      ],
      "title": "CHIEF MEDICAL OFFICER"
    }
  ],
  "ownership": "D",
  "post_shares": "25000",
  "price": "26.1747",
  "row": 2,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "45000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 17, 2026

Exercise or conversion by Collins Helen Louise

Security
Common Stock
Code
M
Shares
45,000
Price per share
2.48
Structured facts
{
  "code": "M",
  "date": "2026-02-17",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2025."
  },
  "owners": [
    {
      "cik": "0001701247",
      "name": "Collins Helen Louise",
      "roles": [
        "officer"
      ],
      "title": "CHIEF MEDICAL OFFICER"
    }
  ],
  "ownership": "D",
  "post_shares": "70000",
  "price": "2.48",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "45000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}